Silence Therapeutics plc Earnings Per Share (Basic)
Silence Therapeutics plc (SLNCF) reported Earnings Per Share (Basic) of -$0.09 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Silence Therapeutics plc earnings per share, basic for the quarter ending 2026-06-30 was -$0.09.
- Silence Therapeutics plc earnings per share, basic for the quarter ending 2026-03-31 was -$0.11.
- Silence Therapeutics plc earnings per share, basic for the quarter ending 2025-12-31 was -$0.08, a 195.65% decline year-over-year.
- Silence Therapeutics plc earnings per share, basic for the quarter ending 2025-09-30 was -$0.15.
- Silence Therapeutics plc earnings per share, basic for fiscal 2025 was -$0.63.
- Silence Therapeutics plc earnings per share, basic for fiscal 2024 was -$0.33.
- Silence Therapeutics plc earnings per share, basic for fiscal 2023 was -$0.49.
- Silence Therapeutics plc earnings per share, basic for fiscal 2022 was -$0.52.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.09 10-Q · filed 2026-08-10 | -$0.19 10-Q · filed 2026-08-10 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2026-03-31 | -$0.11 10-Q · filed 2026-05-07 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.63 10-K · filed 2026-03-05 |
| 2025-09-30 | -$0.15 10-Q · filed 2025-11-06 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.54 10-Q · filed 2025-11-06 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | -$0.19 10-Q · filed 2026-08-10 | -$0.39 10-Q · filed 2026-08-10 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.20 10-Q · filed 2026-05-07 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2024-12-31 | $0.09 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.33 10-K · filed 2026-03-05 |
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-06 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.42 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$0.14 10-Q · filed 2025-08-07 | -$0.16 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.02 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$0.49 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$0.52 10-K · filed 2025-02-27 |